Cargando…
First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852986/ https://www.ncbi.nlm.nih.gov/pubmed/35178640 http://dx.doi.org/10.1007/s10875-022-01228-2 |
| _version_ | 1784653142523117568 |
|---|---|
| author | Kounis, Nicholas G. Koniari, Ioanna Mplani, Virginia Plotas, Panagiotis Tsigkas, Grigorios |
| author_facet | Kounis, Nicholas G. Koniari, Ioanna Mplani, Virginia Plotas, Panagiotis Tsigkas, Grigorios |
| author_sort | Kounis, Nicholas G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8852986 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88529862022-02-18 First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis Kounis, Nicholas G. Koniari, Ioanna Mplani, Virginia Plotas, Panagiotis Tsigkas, Grigorios J Clin Immunol Letter to Editor Springer US 2022-02-17 2022 /pmc/articles/PMC8852986/ /pubmed/35178640 http://dx.doi.org/10.1007/s10875-022-01228-2 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to Editor Kounis, Nicholas G. Koniari, Ioanna Mplani, Virginia Plotas, Panagiotis Tsigkas, Grigorios First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis |
| title | First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis |
| title_full | First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis |
| title_fullStr | First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis |
| title_full_unstemmed | First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis |
| title_short | First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis |
| title_sort | first identified case of fatal fulminant eosinophilic myocarditis following the initial dose of the pfizer-biontech mrna covid-19 vaccine (bnt162b2, comirnaty): an extremely rare idiosyncratic necrotizing hypersensitivity reaction different to hypersensitivity or drug-induced myocarditis |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852986/ https://www.ncbi.nlm.nih.gov/pubmed/35178640 http://dx.doi.org/10.1007/s10875-022-01228-2 |
| work_keys_str_mv | AT kounisnicholasg firstidentifiedcaseoffatalfulminanteosinophilicmyocarditisfollowingtheinitialdoseofthepfizerbiontechmrnacovid19vaccinebnt162b2comirnatyanextremelyrareidiosyncraticnecrotizinghypersensitivityreactiondifferenttohypersensitivityordruginducedmyocarditis AT koniariioanna firstidentifiedcaseoffatalfulminanteosinophilicmyocarditisfollowingtheinitialdoseofthepfizerbiontechmrnacovid19vaccinebnt162b2comirnatyanextremelyrareidiosyncraticnecrotizinghypersensitivityreactiondifferenttohypersensitivityordruginducedmyocarditis AT mplanivirginia firstidentifiedcaseoffatalfulminanteosinophilicmyocarditisfollowingtheinitialdoseofthepfizerbiontechmrnacovid19vaccinebnt162b2comirnatyanextremelyrareidiosyncraticnecrotizinghypersensitivityreactiondifferenttohypersensitivityordruginducedmyocarditis AT plotaspanagiotis firstidentifiedcaseoffatalfulminanteosinophilicmyocarditisfollowingtheinitialdoseofthepfizerbiontechmrnacovid19vaccinebnt162b2comirnatyanextremelyrareidiosyncraticnecrotizinghypersensitivityreactiondifferenttohypersensitivityordruginducedmyocarditis AT tsigkasgrigorios firstidentifiedcaseoffatalfulminanteosinophilicmyocarditisfollowingtheinitialdoseofthepfizerbiontechmrnacovid19vaccinebnt162b2comirnatyanextremelyrareidiosyncraticnecrotizinghypersensitivityreactiondifferenttohypersensitivityordruginducedmyocarditis |